# Sprint 4 — Final traceability review against Sprints 1–3

## Purpose, method and evidence status

This review checks the completed Sprint 4 requirements package against the approved Sprint 1–3 authority chain. It is an internal documentation-alignment review using synthetic project artifacts. It is not implementation evidence, user research, clinical validation, security assessment, interoperability conformance, model evaluation, production-readiness evidence or an outcome claim.

Authority order used:

1. accepted Product Case Charter;
2. approved Sprint 1 Decision Register entries;
3. Sprint 2 Canonical Alignment Register;
4. Sprint 1 state model and transition table;
5. Sprint 2 operating-model, decision-rights, system-of-record and failure-path artifacts;
6. frozen Sprint 3 baseline, scope, stakeholder, decision-rights, FHIR, field, permission, integration and acceptance artifacts; and
7. Sprint 4 artifacts, unless an approved and propagated change is recorded.

Review outcomes mean:

- **Aligned** — Sprint 4 preserves the approved source without material correction.
- **Corrected** — a bounded wording or traceability defect was corrected without changing scope or authority.
- **Gap requiring decision** — the approved sources do not support a safe correction. No such gap remains after this review.

## Artifact coverage

### Sprint 1–3 governing sources reviewed

- Sprint 1: `01_Day_1_Product_Framing/decision_register.csv` D01–D18; `state_transition_table.csv` T01–T14, T11U and E01–E13; `tracer_patient.md`; `mvp_scope.md`; `assumption_register.csv` A01–A12; `care_episode_state_model.md`; `future_state_workflow.md`.
- Sprint 2: `canonical_alignment_register.md`; `decision_rights_matrix.csv` DR01–DR21; `system_of_record_table.csv`; `failure_path_map.md`; `care_episode_operating_model.md`; `mvp_operating_control_table.md`; `sprint_2_baseline_and_traceability.md`; `sprint_2_review_and_exit_checklist.md`.
- Sprint 3: `sprint_3_baseline_and_alignment.md`; `stakeholder_map.md`; `jobs_to_be_done_and_acceptance.md` JTBD/DEP/CTX and CAP-01–CAP-12; `decision_rights_and_ai_suitability_matrix.csv` S3-DR01–S3-DR18; `mvp_scope_freeze.md`; `integration_flow_ehr_launch_to_audit.md`; `fhir_resource_map.md`; `field_mapping.csv` FM-01–FM-26; `permissions_and_interoperability_assumptions.md`; Sprint 3 tracker and final alignment result.

### Sprint 4 artifacts checked

- `Sprint_4_Architecture_and_AI_Operating_Model.md`
- `architecture_principles_and_boundary.md`
- `simplified_architecture.md`
- `smart_on_fhir_launch_sequence.md`
- `synthetic_fhir_resource_definitions.md`
- `event_catalogue_and_recovery_rules.md`
- `ai_service_cards_and_control_matrix.md`
- `audit_and_analytics_data_contract.md`
- `illustrative_hie_deployment_readiness_checklist.md`
- `technical_decisions_and_roadmap_labels.md`
- `decision_clarification_and_propagation_log.md`

## Traceability results

### 1. Canonical states, transitions, amended results and closure

- **Sprint 1–3 authoritative sources:** Sprint 1 `state_transition_table.csv` T01–T14, T11U and E01–E13, especially T04, T05, T06, E05/E06 and T14; Decision Register D14, D16 and D17; Sprint 2 `mvp_operating_control_table.md` core-state rows and `failure_path_map.md` “Amended or corrected result”; Sprint 3 CAP-03/CAP-04/CAP-07/CAP-09, S3-DR03–S3-DR06/S3-DR14/S3-DR17, integration-flow steps 4, 6, 10 and 11, and FM-11–FM-14/FM-23/FM-26.
- **Sprint 4 artifacts checked:** architecture principles AP-04–AP-06 and report-version/closure contracts; simplified architecture “Result, communication and closure evidence”; SMART launch contract steps 6–7; fixture “Resource relationship and state rules” and failure variants; EVT-06–EVT-10, EVT-16–EVT-18 and EVT-22; audit material-event coverage; TDR-05/TDR-07/TDR-13A.
- **Required result:** preserve all 13 core and 10 exception names; keep diagnostic completion, T04 report completeness, T05 assignment and T06 acknowledgement distinct; apply E05/E06 to every amended/corrected version; retain prior acknowledgement as history only; require T14 human-owned closure and pathway-applicable closure evidence.
- **Review outcome:** **Corrected**.
- **Exact evidence reference:** EVT-07 supports T04 only; EVT-09 supports T05; EVT-10 supports T06; EVT-08 applies E05/E06; EVT-22 supports T14. AP-05 states the fixture-specific T04 rule; the architecture “Report-version change and re-review contract” preserves historical acknowledgement and human reassessment; “Minimum closure evidence” preserves the Care Coordinator’s human action.
- **Propagation action taken:** corrected EVT-22 and the audit communication rows to use the approved T14/D17 formulation: required patient communication plus explicit confirmation only where pathway policy requires it. Removed the unsupported shorthand `patient confirmation or approved exception`. Made EVT-06’s `accepted`, `scheduled` and `completed` subtypes trace explicitly to T01, T02 and T03.
- **Evidence-status qualification:** product decisions and validation requirements; documented alignment only. A11 and later synthetic execution/UAT remain unvalidated.

Canonical state set verified: `Order Created`; `Order Accepted`; `Diagnostic Scheduled`; `Diagnostic Completed`; `Result Available`; `Clinical Review Pending`; `Result Acknowledged`; `Follow-up Decision Required`; `Referral Created`; `Referral Accepted`; `Financial Readiness Pending`; `Next Step Confirmed`; `Episode Completed`; `Patient Match Failed`; `Encounter Missing`; `Duplicate Event Suspected`; `Result Incomplete`; `Amended Result Received`; `Clinician Unavailable`; `Referral Rejected`; `Payer Information Missing`; `Authorisation Denied`; `Integration Unavailable`.

### 2. Source-system authority and ContinuumOS workflow ownership

- **Sprint 1–3 authoritative sources:** Decision Register D01/D15; Sprint 2 `system_of_record_table.csv` all information-type rows, especially Patient identity, Encounter, Diagnostic report/version, Workflow task, Referral status, Financial-readiness status and Audit timeline; Sprint 3 baseline “Source authority”, scope freeze, FHIR resource-map “Source authority/Write boundary”, integration-flow “Minimum resource use” and permissions “EHR relationship/Workflow-state ownership”.
- **Sprint 4 artifacts checked:** AP-01/AP-02/AP-13; architecture “Read and write boundary”; simplified architecture external/internal boundaries; SMART launch steps 4 and 7; fixture write boundary; event design rules; audit “Data boundary and ownership”; TDR-01/TDR-03.
- **Required result:** source systems own patient, encounter, clinical diagnostic, referral/receiving, communication and financial records; ContinuumOS owns internal episode linkage, workflow state, tasks, exceptions, evidence references, communication status and workflow history only.
- **Review outcome:** **Aligned**.
- **Exact evidence reference:** AP-02 preserves source identifiers/versions and prohibits silent source correction; the architecture read/write table prohibits clinical order/report correction and decision inference; the audit contract distinguishes source records from internal orchestration evidence.
- **Propagation action taken:** none.
- **Evidence-status qualification:** approved product boundary and proposed requirements; no source integration or write behaviour is implemented.

### 3. Patient, encounter and event linkage; no silent attachment

- **Sprint 1–3 authoritative sources:** Sprint 1 E01–E03, D18, tracer “Where the care episode starts” and A03/A10; Sprint 2 DR03, system-of-record Patient/Encounter/Exception rows and failure-map safety rule; Sprint 3 S3-DR01, FM-01/FM-02/FM-13/FM-17, permissions principles 5/9/12 and integration-flow step 2.
- **Sprint 4 artifacts checked:** AP-03/AP-09; architecture failure contract; simplified architecture linkage layer; SMART launch step 5 and launch/access failures; fixture linkage rules/failure variants; event design rules, EVT-04, EVT-19 and EVT-21; TDR-06.
- **Required result:** verify required patient, encounter, order/event references and versions before attachment; quarantine uncertainty; allow only accountable human reconciliation; do not change source identity/encounter records or attach silently.
- **Review outcome:** **Corrected**.
- **Exact evidence reference:** SMART step 5 records matching inputs, reviewer, recording actor, resolution and safe return; EVT-04 is the association gate; AP-03 assigns the Identity reconciliation reviewer and restricts manual reconciliation to an internal reference.
- **Propagation action taken:** expanded EVT-04 from patient/encounter/order shorthand to patient/encounter/order/event references with source identifiers/versions, explicit verified-reference scope, `Duplicate Event Suspected`/quarantine handling for event conflict, and the prohibition on source-record alteration.
- **Evidence-status qualification:** product decision and validation requirement; production matching/MPI and tested linkage thresholds remain deferred.

### 4. Human decision rights and role boundaries

- **Sprint 1–3 authoritative sources:** Sprint 1 T06, T08–T14, T11U, E01/E02/E05–E12 and D07/D12/D17/D18; Sprint 2 Canonical Roles and DR03/DR08–DR19; Sprint 3 stakeholder-map authority rows, S3-DR01–S3-DR18 and permissions role matrix.
- **Sprint 4 artifacts checked:** AP-06/AP-08; architecture human/deterministic/AI boundary and minimum closure evidence; simplified architecture user actions; SMART operations-access boundary; EVT-04/EVT-09–EVT-18/EVT-22; AI service-card human-owner rows; HIE “Workflow and human authority”; TDR-02/TDR-13A/TDR-13C.
- **Required result:** Identity reconciliation reviewer controls linkage; clinic physician controls review, acknowledgement, clinical direction and clinical content; Referral Coordinator prepares/routes/tracks; receiving team accepts/rejects; authorised financial decision-maker controls final financial decision; authorised sender records communication; patient/caregiver supplies applicable confirmation; Care Coordinator verifies evidence and performs T14 closure without gaining clinical authority.
- **Review outcome:** **Aligned**.
- **Exact evidence reference:** EVT-10 requires clinic-physician acknowledgement; EVT-11 requires clinic-physician direction; EVT-12/13 separate package preparation/routing; EVT-14 requires receiving-team response; EVT-15 requires the authorised financial decision-maker; EVT-16 assigns evidence verification to the Care Coordinator; EVT-17/18 separate authorised delivery and patient confirmation; EVT-22 requires the accountable closer.
- **Propagation action taken:** the EVT-22 correction restores the pathway-applicable communication/confirmation boundary; no role or authority changed.
- **Evidence-status qualification:** product decisions and requirements; no stakeholder confirmation, clinical validation or operating-policy approval is claimed. D12 remains a proposed operating policy requiring later review.

### 5. Synthetic FHIR, internal Task, SMART and access boundary

- **Sprint 1–3 authoritative sources:** D02/D04/D15; Sprint 3 FHIR map resource boundary; FM-01–FM-15/FM-18/FM-24; permissions principles 8/10, SMART and non-SMART access assumptions, candidate scopes and security context; integration-flow steps 1–4 and write/outage rules.
- **Sprint 4 artifacts checked:** AP-08/AP-12/AP-13 and S4-AD02/S4-AD03/S4-AD12/S4-AD13; simplified architecture access layer; SMART sequence launch contract, candidate scopes and separate operations access; all fixture examples and write boundary; event access/source families; audit launch/retrieval fields; TDR-02/TDR-03.
- **Required result:** six synthetic FHIR R4-shaped source types only; separate internal `continuum_task`; clinician-only SMART launch; separate operations access; candidate read-only scopes; no source write; no raw-token/secret/full-authorisation-response storage.
- **Review outcome:** **Aligned**.
- **Exact evidence reference:** SMART candidate scopes are `launch`, `openid`, `fhirUser`, five patient-read/search scopes and `user/Practitioner.r`; no write scope is proposed. Fixture “Resource boundary” lists the six source types and separates the internal Task. EVT-01–EVT-03 and the audit contract retain only non-sensitive access/retrieval evidence.
- **Propagation action taken:** none.
- **Evidence-status qualification:** synthetic requirements and proposed demonstration configuration; not live OAuth, FHIR server conformance, production security or successful execution.

### 6. Event semantics, idempotency, review assignment, referral, confirmation, closure and recovery

- **Sprint 1–3 authoritative sources:** Sprint 1 transition table; D13/D14/D16–D18; Sprint 2 failure-map cross-cutting recovery rule; Sprint 3 CAP-09/CAP-11, S3-DR13/S3-DR18, FM-24/FM-25 and integration-flow deterministic/write/outage rules.
- **Sprint 4 artifacts checked:** AP-09–AP-11; SMART failure rules; EVT-01–EVT-22, idempotency contract and recovery matrix; audit one-event/many-entry contract; TDR-04/TDR-05/TDR-07/TDR-11/TDR-12/TDR-13A.
- **Required result:** stable event identity, semantic once-only progression, distinct report availability/assignment/acknowledgement events, version-aware amendment handling, distinct referral/send/receiving/communication/confirmation/closure events and safe recovery to the last verified state.
- **Review outcome:** **Corrected**.
- **Exact evidence reference:** EVT-07/09/10 separate T04/T05/T06; EVT-08 marks dependent work stale without automatic reversal; EVT-12–EVT-18 separate handoff and communication authorities; EVT-21 records verified recovery; EVT-22 records T14 closure. Idempotency rules prohibit receive-time-only keys and duplicate advancement.
- **Propagation action taken:** made EVT-06 transition mappings explicit; tightened EVT-04 event-linkage handling; corrected EVT-22 and recovery wording; replaced stale “later event catalogue/AI cards” wording in the governing architecture, simplified architecture, event catalogue and tracker with current file references.
- **Evidence-status qualification:** proposed event/recovery contract only; no broker, exactly-once transport, replay implementation or production recovery evidence.

### 7. AI scope, optionality, provenance, staleness and human review

- **Sprint 1–3 authoritative sources:** D05–D07/D13/D15; A05/A07/A12; Sprint 2 Canonical MVP AI Scope and DR12/DR13/DR20; Sprint 3 CAP-10/CAP-12, S3-DR07/S3-DR15 and permissions principles 6/11.
- **Sprint 4 artifacts checked:** AP-07/AP-13; architecture AI boundary; simplified architecture AI layer; SMART AI-failure rule; EVT-08/EVT-20; both AI service cards and control matrix; audit AI dispositions/metrics; TDR-08–TDR-10.
- **Required result:** only source-linked episode summary and post-approval referral-handoff draft; deterministic checks remain non-AI; AI is optional, minimum-data, source-linked, version-aware, stale-aware and human-reviewed; failure does not block valid workflow.
- **Review outcome:** **Aligned**.
- **Exact evidence reference:** AI-01 is orientation only; AI-02 requires EVT-11 before generation and human approval before EVT-12; EVT-20 has the shared disposition set and no state effect; EVT-08 marks dependent drafts stale. Missing-owner, overdue, duplicate, incomplete-result, missing-handoff and unavailable-service checks remain deterministic.
- **Propagation action taken:** updated D13–D15 propagation statuses to record that the event, AI and audit requirements artifacts now exist; later UAT/prototype obligations remain open.
- **Evidence-status qualification:** proposed controls and unvalidated pilot hypotheses; no model choice, call, performance, safety or outcome claim.

### 8. Audit correction, minimum data and non-triggering analytics

- **Sprint 1–3 authoritative sources:** D15–D17; Sprint 2 system-of-record “Audit timeline”; Sprint 3 CAP-09, S3-DR17, FM-24–FM-26, permissions principles 7–10 and integration-flow audit contract.
- **Sprint 4 artifacts checked:** AP-11/AP-13/AP-14; simplified architecture evidence/measurement layer; event idempotency/correction rules; AI storage/audit controls; complete audit and analytics contract; TDR-10–TDR-12.
- **Required result:** corrections append linked evidence; one logical event may have many audit entries; retain minimum necessary references rather than full payloads; analytics is read-only and cannot trigger tasks, state, AI, communication or decisions.
- **Review outcome:** **Corrected**.
- **Exact evidence reference:** audit “Canonical audit-event contract” assigns a unique `audit_id` to receipt, validation, outcome, review, correction and recovery entries sharing one `event_id`; correction fields are `correction_of`/`supersedes_ref`; measurement governance prohibits metric-triggered workflow action.
- **Propagation action taken:** corrected communication/confirmation audit coverage and metric denominator wording to follow pathway applicability; updated D16/D17 propagation status to include the completed event and audit contracts.
- **Evidence-status qualification:** target audit behaviour and proposed read-only measurement contract; no immutable store, retention control, dashboard, metric result or automated control is implemented.

### 9. HIE and roadmap language

- **Sprint 1–3 authoritative sources:** D08/D09/D11; Sprint 1 MVP scope represent/defer sections; Sprint 3 scope freeze deferred capabilities and permissions/interoperability deferred boundaries.
- **Sprint 4 artifacts checked:** AP-12 and deferred/future architecture context; simplified architecture classification; SMART/fixture scope tables; HIE checklist purpose, readiness gate, all status rows and out-of-scope section; complete technical decisions/roadmap register, especially TDR-14/TDR-15.
- **Required result:** HIE and multi-organisation exchange remain future-readiness questions only; no connectivity, participant readiness, deployment, conformance, security, consent, legal or production claim.
- **Review outcome:** **Aligned**.
- **Exact evidence reference:** every HIE checklist row is `Not assessed`; the readiness gate grants no connection, exchange, write-back, patient-facing or automated-workflow permission; TDR-14 labels identity, consent, security, residency, terminology, conformance and participation as future readiness; TDR-15 keeps excluded platform/care scope deferred.
- **Propagation action taken:** none.
- **Evidence-status qualification:** illustrative future-readiness checklist and roadmap labels only; no pilot or deployment approval.

## Corrections made during this review

| Correction ID | Defect | Files corrected | Result |
|---|---|---|---|
| S4-TRC-01 | EVT-22/audit shorthand implied patient confirmation or an undefined approved exception, which did not match pathway-applicable T14/D17 evidence. | `event_catalogue_and_recovery_rules.md`; `audit_and_analytics_data_contract.md` | Restored required communication plus explicit confirmation only where policy requires it; delivery remains insufficient. |
| S4-TRC-02 | EVT-04 did not state event-reference/version linkage and event-conflict handling precisely enough for D18/E03. | `event_catalogue_and_recovery_rules.md` | Added event refs/versions, verified-reference scope, quarantine/`Duplicate Event Suspected` handling and no source-record alteration. |
| S4-TRC-03 | EVT-06 did not name the exact transition mapped by each operational subtype. | `event_catalogue_and_recovery_rules.md` | Mapped accepted/scheduled/completed explicitly to T01/T02/T03. |
| S4-TRC-04 | Several artifacts still described completed Sprint 4 contracts as future artifacts. | `architecture_principles_and_boundary.md`; `simplified_architecture.md`; `event_catalogue_and_recovery_rules.md`; `decision_clarification_and_propagation_log.md`; Sprint 4 tracker | Replaced stale carry-forward wording with current references; retained only UAT/prototype obligations as future work. |

No correction creates a state, role, capability, integration, source authority, evidence requirement or production claim.

## Validation result

- CSV structure: governing Sprint 1–3 CSVs parsed with consistent column counts and unique primary IDs; no CSV was edited in this review.
- JSON fixtures: every JSON code block in `synthetic_fhir_resource_definitions.md` parsed successfully.
- Events: EVT-01–EVT-22 are unique; referenced event IDs/names resolve; T01/T02/T03 and T04/T05/T06/E05/E06/T14 mappings were checked.
- Mermaid: Sprint 4 Mermaid fences and diagram declarations are structurally balanced; no Mermaid artifact was changed structurally.
- Cross-artifact searches: no remaining `approved exception` closure shorthand; no stale “later event catalogue/AI cards” obligation; no mixed Sprint 4 completion checkbox; no unsupported claim of live integration, production readiness, security certification, clinical validation, model performance or achieved outcome.

## Final verdict

**Aligned after four bounded documentation corrections.** Sprint 4 preserves the approved Sprint 1–3 states, transitions, role authority, source ownership, linkage controls, data/access boundaries, event and recovery semantics, AI limits, audit/analytics controls and future-readiness language.

No unresolved material traceability gap requires a product decision. Open assumptions, pilot hypotheses, D12 policy review, UAT/prototype evidence and all production-readiness work remain open exactly as previously classified. Sprint 4 is genuinely complete as a requirements-level documentation package; this does not imply implementation or validation.
